Fund comparison · from official SEC filings

BIB vs GNOM: how much do they overlap?

ProShares Ultra Nasdaq Biotechnology and Global X Genomics & Biotechnology ETF
Holdings overlap
14%
of assets, by weight
Shared positions
31
of 259 / 51 holdings
BIB expense ratio
0.95%
net, per year
GNOM expense ratio
0.50%
net, per year
Shared holdings
Company
BIB
GNOM
G
GHGUARDANT HEALTH INC
0.95%
5.43%
G
GILDGILEAD SCIENCES INC
5.19%
1.90%
V
VRTXVERTEX PHARMACEUTICALS INC
5.18%
3.84%
I
ILMNILLUMINA INC
1.39%
4.68%
B
BMRNBIOMARIN PHARMACEUTICAL INC
0.62%
3.97%
A
ARWRARROWHEAD PHARMACEUTICALS IN
0.61%
3.95%
L
LEGNLEGEND BIOTECH CORP-ADR
0.13%
3.93%
P
PRAXPRAXIS PRECISION MEDICINES I
0.54%
3.89%
T
TWSTTWIST BIOSCIENCE CORP
0.23%
3.85%
C
CRSPCRISPR THERAPEUTICS AG
0.30%
3.74%
V
VCYTVERACYTE INC
0.21%
3.53%
B
BNTXBIONTECH SE-ADR
0.61%
3.31%
M
MRNAMODERNA INC
1.04%
3.18%
T
TXG10X GENOMICS INC-CLASS A
0.19%
3.14%
B
BEAMBEAM THERAPEUTICS INC
0.19%
3.00%
R
RAREULTRAGENYX PHARMACEUTICAL IN
0.13%
2.19%
C
CAICARIS LIFE SCIENCES INC
0.26%
1.97%
S
SRPTSAREPTA THERAPEUTICS INC
0.10%
1.75%
Q
QUREUNIQURE NV
0.10%
1.55%
N
NTLAINTELLIA THERAPEUTICS INC
0.09%
1.55%
S
STOKSTOKE THERAPEUTICS INC
0.10%
1.41%
V
VIRVIR BIOTECHNOLOGY INC
0.08%
1.08%
W
WVEWAVE LIFE SCIENCES LTD
0.07%
1.00%
P
PSNLPERSONALIS INC
0.07%
0.76%
M
MRVIMARAVAI LIFESCIENCES HLDGS-A
0.04%
0.49%
Only in BIB
?
N/A
17.83%
I
IQMMPROSHARES GENIUS MNY MKT ETF
7.57%
A
AMGNAMGEN INC
4.99%
R
REGNREGENERON PHARMACEUTICALS
3.57%
?
Repurchase Agreement
3.50%
A
ALNYALNYLAM PHARMACEUTICALS INC
2.24%
R
RVMDREVOLUTION MEDICINES INC
1.74%
B
BIIBBIOGEN INC
1.61%
U
UTHRUNITED THERAPEUTICS CORP
1.36%
R
RPRXROYALTY PHARMA PLC- CL A
1.34%
A
ARGXARGENX SE - ADR
1.33%
I
INSMINSMED INC
1.29%
R
ROIVROIVANT SCIENCES LTD
1.20%
I
INCYINCYTE CORP
1.08%
V
VTRSVIATRIS INC
1.05%
A
AGPXXINVESCO GVT & AGNCY-INST
0.90%
N
NBIXNEUROCRINE BIOSCIENCES INC
0.89%
J
JAZZJAZZ PHARMACEUTICALS PLC
0.81%
A
ASNDASCENDIS PHARMA A/S
0.77%
S
SMMTSUMMIT THERAPEUTICS INC
0.76%
E
EXELEXELIXIS INC
0.73%
B
BBIOBRIDGEBIO PHARMA INC
0.72%
M
MEDPMEDPACE HOLDINGS INC
0.71%
I
IONSIONIS PHARMACEUTICALS INC
0.71%
A
AXSMAXSOME THERAPEUTICS INC
0.67%
Only in GNOM
N
NTRANATERA INC
4.03%
Q
QGENQIAGEN N.V.
3.43%
T
TECHBIO-TECHNE CORP
3.31%
?
BNYREPOS
2.96%
L
LLYELI LILLY & CO
2.25%
G
GNNSFGENSCRIPT BIOTECH CORP
1.94%
B
BLLNBILLIONTOONE INC CL A
1.92%
A
AZNASTRAZENECA PLC
1.78%
W
WGSGENEDX HOLDINGS CORP
1.31%
D
DHRDANAHER CORP
1.14%
B
BMYBRISTOL-MYERS SQUIBB CO
1.12%
C
CDNACAREDX INC
1.02%
B
BRKRBRUKER CORP
0.42%
B
BNTCBENITEC BIOPHARMA INC
0.37%
A
AAGILENT TECHNOLOGIES INC
0.37%
F
FLGTFULGENT GENETICS INC
0.35%
L
LABSTANDARD BIOTOOLS INC
0.34%
M
MYGNMYRIAD GENETICS INC
0.34%
M
MLABMESA LABORATORIES INC
0.28%
D
DGXQUEST DIAGNOSTICS INC
0.27%
Hold BIB and GNOM together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.
BIB vs GNOM: 14% holdings overlap — Unwrap.Fund